Head-to-head · verified 2026-08-05
Big Easy Weight Loss vs. Oak Longevity: prices, fine print, and the honest verdict
Published pricing is incomplete on at least one side, so this matchup compares what can be verified — disclosure, terms, model — and says plainly where you'll need figures in writing.
- Big Easy Weight Loss
- Tirzepatide, all-in at 10 mg
- Offered — no published price
- Semaglutide, all-in
- Offered — no published price
- Membership fee
- None
- Commitment
- unknown
- Cancellation
- not published
- Pharmacy
- not named
- Price evidence
- No price published
- Last verified
- 2026-08-05
- Oak Longevity
- Tirzepatide, all-in at 10 mg
- Not offered
- Semaglutide, all-in
- $133/mo
- Membership fee
- None
- Commitment
- none stated
- Cancellation
- no subscription
- Pharmacy
- not named
- Price evidence
- Source-verified
- Last verified
- 2026-08-08
Tirzepatide pricing
Big Easy Weight Loss offers tirzepatide without a published price we could capture. Oak Longevity does not offer tirzepatide.
Semaglutide pricing
Only Oak Longevity publishes a semaglutide price here: Semaglutide runs $133 a month all-in. Big Easy Weight Loss offers semaglutide without a published price.
Transparency
Big Easy Weight Loss: No price published (verified 2026-08-05); dispensing pharmacy not publicly named. Oak Longevity: Source-verified (verified 2026-08-08); dispensing pharmacy not publicly named. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.
Commitment & cancellation
Big Easy Weight Loss: unknown; not published. Oak Longevity: none stated; no subscription.
Big Easy Weight Loss: no published price captured; Oak Longevity: no published price captured; semaglutide: Oak Longevity $133; verified floor $215 (NexLife); brand rails $349–$449. Basis: all-in monthly, 10 mg maintenance, capture-dated in the dataset.
The semaglutide board
Only Oak Longevity fields a verified semaglutide price here — $133/month all-in (#1 of 19) — while Big Easy Weight Loss publishes no semaglutide figure we could capture. For a buyer starting on the cheaper molecule with a likely upgrade later, single-molecule programs mean a future re-shop; dual-molecule ones price the whole arc.
The five normalizations, applied to this pair
1 · All-in, not advertised. Big Easy Weight Loss publishes no figure to normalize; Oak Longevity publishes no figure to normalize. 4 · Evidence tiered. Big Easy Weight Loss: no price published, read 2026-08-05; Oak Longevity: source-verified, read 2026-08-08. 5 · Pharmacy weighed. Big Easy Weight Loss names no pharmacy; Oak Longevity names no pharmacy — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.
Fine print, itemized
Big Easy Weight Loss: no membership — the medication figure is the billed figure; not published; commitment: unknown. Oak Longevity: no membership — the medication figure is the billed figure; no subscription; commitment: none stated. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.
Transparency, audited
Big Easy Weight Loss carries no price published pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Oak Longevity carries source-verified pricing (last read 2026-08-08); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.
Switching between them
Moving from Big Easy Weight Loss to Oak Longevity (or back) is administratively unglamorous: complete the new program's intake, let its prescriber issue a fresh prescription to its pharmacy, and cancel the old subscription in writing — prescriptions don't transfer between telehealth programs, and neither do prepaid balances, which is the quiet reason month-to-month terms are worth their premium.
Refills, shipping, and the week-to-week reality
The unglamorous layer — how the medication actually reaches you and stays on schedule — splits like this: Big Easy Weight Loss: shipping unknown; consultation unknown. Oak Longevity: shipping included; consultation included; async visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.
Who should pick which
Pick Big Easy Weight Loss if its published terms happen to fit your state, format, or timing. Pick Oak Longevity if its published terms happen to fit your state, format, or timing. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.
What verification would take
For Big Easy Weight Loss, ranking would require: any published price at all, on a page we can capture and date; the dose structure (flat or scaled, with the 10 mg tier stated); the pharmacy's name, 503A/503B status, and state licensure; commitment and cancellation terms verbatim. We publish the checklist because the gap is fixable — providers that clear it get ranked on the same arithmetic as everyone else, and readers who ask these questions get the answers this page can't yet print.
If neither one fits
The dataset's bench is deep; the closest verified third options to this matchup's price band are NexLife at $215 (flat, no membership, named pharmacy); Yucca Health at $258 (flat, no membership); IVIM Health at $278 (dose-scaled, $75 membership included) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.
The verdict
With incomplete published pricing on one or both sides, get current figures in writing before enrolling with either. Both records, with dates and sources, live in the pricing database.
Quick answers
Which is cheaper, Big Easy Weight Loss or Oak Longevity?
Published pricing is incomplete on at least one side; the honest answer is to request current all-in figures in writing from both.
Can I switch between them?
Yes — patients move between telehealth programs routinely; you'll complete the new program's intake and prescriptions restart there. If you're also switching molecule or from compounded to brand, loop in the prescriber; our switching guide covers the clinical side.
Which is easier to cancel, Big Easy Weight Loss or Oak Longevity?
Big Easy Weight Loss: not published Oak Longevity: no subscription Cancel in writing either way; memberships cancel separately.
Is there a brand alternative to both?
Yes — Zepbound at $299–$449 via LillyDirect/retail (about $350 on TrumpRx; ~$50 for newly eligible Medicare patients) and Wegovy at a flat $349: FDA-approved products whose prices now sit close enough to make the comparison real.